Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of rare genetic variants for rotator cuff tearing and repair in high-risk pedigrees. | JSES Int | 2024 | 39035665 | PubTator, text mining | PubMed |
| Assembly and activation of EBV latent membrane protein 1. | Cell | 2024 | 38996527 | PubTator, text mining | PubMed |
| Association between Epstein-Barr virus LMP-1 and Hodgkin lymphoma LMP-1 mechanisms in Hodgkin lymphoma development. | Rev Med Virol | 2024 | 38877989 | PubTator, text mining | PubMed |
| OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy. | Proc Natl Acad Sci U S A | 2024 | 38838015 | PubTator, text mining | PubMed |
| Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway. | bioRxiv | 2024 | 38826197 | PubTator, text mining | PubMed |
| Follicular lymphoma with Epstein-Barr virus-associated transformation: A case report and review of the literature. | J Clin Exp Hematop | 2024 | 38811196 | PubTator, text mining | PubMed |
| The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program. | bioRxiv | 2024 | 38766209 | PubTator, text mining | PubMed |
| Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression. | PLoS Pathog | 2024 | 38683861 | PubTator, text mining | PubMed |
| Unlocking new dimensions in long-acting injectables using lipid mesophase-based beads. | J Colloid Interface Sci | 2024 | 38521004 | PubTator, text mining | PubMed |
| The Antigen-Processing Pathway via Major Histocompatibility Complex I as a New Perspective in the Diagnosis and Treatment of Endometriosis. | Arch Immunol Ther Exp (Warsz) | 2024 | 38478380 | PubTator, text mining | PubMed |
| Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy. | Int J Mol Sci | 2024 | 38473926 | PubTator, text mining | PubMed |
| Post cross-linked ROS-responsive poly(β-amino ester)-plasmid polyplex NPs for gene therapy of EBV-associated nasopharyngeal carcinoma. | J Mater Chem B | 2024 | 38451208 | PubTator, text mining | PubMed |
| Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications. | Ann Diagn Pathol | 2024 | 38447253 | PubTator, text mining | PubMed |
| Dynamic bidirectional regulation of NLRC3 and gammaherpesviruses during viral latency in B lymphocytes. | J Med Virol | 2024 | 38445794 | PubTator, text mining | PubMed |
| Distribution of Epstein-Barr virus in the oral cavity of Thais with various oral mucosal conditions. | Heliyon | 2024 | 38293426 | PubTator, text mining | PubMed |
| Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. | Blood | 2024 | 38277625 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells. | Sci Rep | 2024 | 38273037 | PubTator, text mining | PubMed |
| Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children. | Sci Rep | 2024 | 38273012 | PubTator, text mining | PubMed |
| Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression. | bioRxiv | 2024 | 38260430 | PubTator, text mining | PubMed |
| Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation. | bioRxiv | 2024 | 38260266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=8